prof. Dr. Ali Kutlu made a sharing that clearly revealed which vaccine should be given as the 3rd dose on top of 2 doses of Sinovac. According to the data we have now, taking the 3rd dose of BioNTech increases the antibody level to almost 100%.
The severity and lethality of the COVID-19 pandemic, which we still cannot bring to an end, has been brought under control thanks to the vaccines released so far. However, previous vaccines need to be developed in order to find a vaccine that provides all or at least long-term protection when taken. So until that happens, we have to be concerned with how strong and how long-lasting protection current vaccines provide.
In the past weeks, the BioNTech vaccine has been approved by the FDA and EMA as it loses its protection after 6 months. 3. dose confirmation had received. We learned months ago that Sinovac loses its effect after the third month. There is not enough data yet on which vaccine would be better for those who have 2 doses of Sinovac vaccine, but if we are satisfied with the data we have, BioNTech is the answer.
Protection goes up to almost 100% with BioNTech
Allergy Immunology and Chest Diseases Specialist Prof. Dr. Ali Kutlu shared on Twitter which vaccine would make more sense to have 2 doses of Sinovac. Stating that there is not much data on this subject, Kutlu presented a table prepared according to the data obtained in Chile to people who have question marks on this subject. According to the data, revaccination of Sinovac after 2 doses of Sinovac increased the antibody rate from 54% to 74%, Getting the 3rd dose of BioNTech vaccine increases this rate to 95%..
RELATED NEWS
BioNTech’s Founders Özlem Türeci and Uğur Şahin: COVID-19 Will Achieve Influenza Status
Whether it will be the 3rd and maybe even the 4th dose, or even more than this, is one of the most curious topics in the pandemic field at the moment. As we mentioned at the beginning, the long-term protection of a vaccine also depends on the updates it will receive after its release. One of the founding partners of BioNTech, Prof. Dr. Ugur Sahin, vaccine formula will change had previously announced. It is a mystery when there will be a time when this dose of talk will no longer be needed.